Short Communication - Comparision of microscopy and RDTs techniques for laboratory detection of malaria by Samane, AK et al.
African Journal of Biotechnology Vol. 9(10), pp. 1514-1516, 8 March, 2010     
Available online at http://www.academicjournals.org/AJB 







Comparision of microscopy and RDTs techniques for 
laboratory detection of malaria 
 
Abdolahi Khabisi Samane1*, Hosein Zadeh Nahid1, Shahabi Saaed1, Hushang Khazan1, 
Haghighi Ali1, Raisii Ahmad2, Edrissian Gholam hosein3 and Abadi alireza4 
 
1Department of Parasitology and Mycology, Shahid Beheshti Medical 
University,Tehran, Iran. 
2Center of Malaria Control and Prevention, Tehran, Iran. 
3School of Public Health and Institute of Public Health Research, Tehran University of 
Medical Sciences, Tehran, Iran. 
4Medical Social Department, Shahid Beheshti Medical University, Tehran, Iran. 
 
Accepted 25 January, 2010 
 
The development of rapid and specific diagnostic test to identify individuals infected with malaria is 
important to control severe public health impact of this disease.This study evaluated the ability of rapid 
malaria diagnostic test (BIOTEC Malaria P.v/P.f rapid device) to detect Plasmodium falciparum and 
Plasmodium vivax malaria during out break in Chabahar province of Sistan and Balouchestan in Iran. 
Whole blood samples were obtained from 250 suspected malaria patients. Results from these kit were 
compared to the reading obtained from 100 fields of Giemsa-stained thick smear blood film.This test is 
rapid (15 min) for malaria detection. The device is coated with monoclonal antibodies against P. 
falciparum histidine rich protein-2 (PfHRP2) and enzyme parasite lactate dehydrogenase isomer of P. 
vivax (PLDH) . A total of 55% samples (138 of 250) were positive by blood films, while 54% samples (136 
of 250) were positive by malaria P.v/P.f rapid device. The blood film indicated that 81% (112 of 138) of 
patients were positive for P.vivax and 19% (26 of 138) of patients were positive for P. falciparum. The 
malaria P.v/P.f rapid device showed that 79.6% (110 of 138) were positive for P.vivax and 1.4% (2 of 138) 
were negative. 19% (26 of 138) were positive for P. falciparum. These results demonstrated that the 
malaria P.v/P.f rapid device had sensitivity of 98.5% and specificity of 100% when compared to 
traditional blood films. The malaria P.v/P.f rapid device showed an excellent correlation with traditional 
blood films in identification of both P. vivax and P. falciparum malaria. At present for diagnosis of 
malaria in endemic area, this kit is rather expensive when compared to microscopy. Neverthless, it is 
very useful for remote areas where the necessary facilities for microscopic examination are not 
accessible. 
 





In order to control the severe public health impact of 
malaria, the development of rapid and specific diagnostic 
tests to identify individuals infected with this disease is 
important. Early diagnosis and treatment of parasitemia is 
vital for the control of malaria, one of the most prevalent 
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of thick blood film is currently the standard method for 
malaria diagnosis. Microscopic examination howerver, 
requires well trained and experienced malaria micro-
scopists and it is also rather time consuming (Iqbal et. al., 
2001, Edrissian et. al., 2001). The World Health Organi-
zation (WHO) has repeatedly emphasized the urgent 
need for simple and cost effective diagnostic tests for 
malaria to over come the deficiencies of both light micro-
scopy and clinical diagnosis (Russell et. al., 2002). Using 
 rapid diagnostic tests (RDTs) to distinguish fevers 





availability of a simple and accurate test could greatly aid 
in the diagnosis of malaria in travelers returning to their 
home countries (Jelinek et. al., 1999). RDTs can detect 
Plasmodium falciparum infection even when the parasite 
is sequestered in deep vascular compartment. In case of 
mixed infection, one specie often suppresses the other, 
thereby making detection of the suppressed one difficult 
(Ritabrata et. al., 2005). As health programs in malaria 
endemic countries implement artmisinin combination 
therapy (ACT). ACT is currently much more expensive 
than older anti malarials such as chloroquin (CQ). RDTs 
can help target ACTs to patients who really have malaria. 
Finally, avoiding unnecessary use of ACTs on patients 
who do not have malaria may help prevent or delay drug 




MATERIALS AND METHODS 
 
The study was performed from June to November 2008 in Chaba-
har of south province Sistan and Blouchestan of Iran. The blood 
samples were collected during a malaria out break from individuals 




Patient and sample collection: 
 
From 250 suspected malaria patients with symptoms including fever 
and/or chills of several days, samples were collected. At the start of 
the study, informed consent and demographic information were 
obtained from all individuals who participated in the study. Sample 
collection was performed in active and passive surveillance program. In 
passive sample collection, finger prick blood samples were 
collected from suspected malaria patients who were referred to the 
health centers of Chabahar while active collection sample, was 
done house to house in the villages and urban centres of Chabahar. 
In addition, each individual was asked about signs and symptoms 
of malaria as well as any drug used within the last 2 weeks. Three 
drops of finger prick blood samples were used for the thick smear, 1 
drop was used for thin blood smear and 5 µl was used for rapid 
diagnostic test (RDT). 
 
 
Microscopy of Geimsa –stained blood films 
 
Thick and thin blood smears were stained with Geimsa stain (pH 
7.2) for 20 -30 min and examined by two experienced microscopists 
who had no knowledge of patient disease to avoid any bias. The 
smears were analyzed by x1000 magnification for the presence of 
malaria parasites. The research was blinded as results from the 
microscopic examination were not allowed to interfered with the 
RDTs results until all samples were examined. 
 
 
The BIOTEC malaria P. vivax/P. falciparum (Pv/Pf) rapid device 
 
All whole blood samples were tested with this kit. The BIOTEC 
malaria Pv/Pf rapid device was coated with monoclonal antibidies 
against the interacellular metabolic enzyme, plasmodium lactate 
dehydrogenase (PLDH), specific Plasmodium vivax and P. falciparum 
Histidine Rich Protein-2 (P.f HRP2) antigens. Detection system for 
P. falciparum was based on the detection of P. falciparum specific 
histidine rich protein-2 (P.f HRP2) which is a  water  soluble  protein  




that is released from infected red blood cells (RBCs). The detection 
system of P. vivax was based on the presence of P. vivax specific 
PLDH. The test used clearing buffer in a dropper bottle and desiccant 
pounch and 5 µl sample loop. After retrieving 5 µl sample with 
calibrated loop, this sample was delivered to the sample pad in the 
sample port A. Immediately, four drops of clearing buffer was added 




Principles of the method 
 
As the test sample flows through the membrane assembly, after 
addition of the clearing buffer, the coloured colloidal gold conjugates 
of anti Pf HRP2 antibody and anti P. vivax specific PLDH antibody 
complexes the HRP2/PLDH antigen in the lysed sample. This 
complex moves further on the membrane to the test region where it 
was immobilised by the monoclonal anti Pf HRP2 antibody and/or 
monoclonal anti P. vivax specific PLDH antibody coated on the 
membrane. This led to the formation of a pink-purple coloured band 
in the respective regions which confirmed a positive test results. 
Absence of a coloured band in the test region indicated a negative 





A total of 250 blood samples were analyzed for malaria 
parasites by the RDT method and the results were 
compared to results obtained from reading thin and thick 
blood smear. The blood smear results indicated that 55% 
(138 of 250) of patients were infected with malaria. 
Among the positive patients samples, P. vivax was 
present in 81% (112 of 138) and P. falciparum was present 
in 19% (26 of 138). The RDTs results indicated that 54% 
(136 of 250) of the patients were infected with malaria. 
Among the positive patients samples, P. vivax was 
present in 79.6% (110 of 136) and P. falciparum was 
present in 19% (26 of 136). However, 2 cases detected 
by the blood film P. vivax were not detected with RDT. 
The BIOTEC malaria Pv/Pf rapid device had sensitivity of 
98.5% (95%[CI], 96.5 to 100%) and specificity of 100% 
(95%[CI]) when compared to traditional blood films for 
detection of malaria. The BIOTEC malaria Pv/Pf rapid 
device had sensitivity of 98.2% (95%[CI], 96.2 to 100%), 
specificity of 100% (95%[CI]), positive predictive value of 
100% (95%[CI]) and negative predictive value of 98.6% 
(95%[CI], 96.6 to 100%) when compared to traditional 
blood films for detection P. vivax. The BIOTEC Malaria 
Pv/Pf Rapid Device had sensitivity, specificity, positive 
predictive value and negative predictive value of 100% 
(95%[CI]) when compared to traditional blood films for 





This study compared the microscopy method and BIOTEC 
rapid device for detection of malaria. The important finding 
of this study was that BIOTEC rapid device, had 
sensitivity of 98.5% and specificity of 100% compared to 
microscopy method for detection of malaria. Out of a total  









samples Positive Negative 
Sensitivity Specificity Positive predictive value 
Negative predictive                
value 
Positive 138 136 2 98.5%  100%  
Negative 0 0 138  100%  98.6% 






















(96.6 - 100)% P.V  
Negative  0 2     
Positive  26 26 100% 100% 100% 100%  
P.F  Negative 0 0     
Positive  0 0      
Control  Negative  138 138     




of 250 suspected malaria patients, 55% were positive by 
microscopy method and 54% of them were positive by 
BIOTEC rapid device. Although in this study, two samples 
were positive by microscopy method as trophozoit of P. 
vivax was seen in their blood films, these two samples 
were negative by BIOTEC rapid device. It is possible that 
the two patients infected with malaria started treatment 
with anti malaria drugs when symptoms of malaria 
appeared. As PLDH are produced only from living para-
sities and medication could have led to the death of 
parasities, PLDH test was negative (Carol et. al., 1998). 
Alternatively, the results showed that the BIOTEC rapid 
device had high sensitivity and specificity compared to 
microscopy method for detection of P. falciparum and P. 
vivax. Therfore, this test can be useful for remote areas 
of Iran which have no facilities for microscopy method 
and prevent presumptive treatment using anti-malaria 
drugs such as chloroquin and artmisinine. This could 
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